Y.D. Adler

Adamantiades-Behçet’s Disease: Serum IL-8 Is a More Reliable Marker for Disease Activity than C-Reactive Protein and Erythrocyte Sedimentation Rate

Joannis Katsantonis, Y.D. Adler, Constantin E. Orfanos et al. · Dermatology · 2000 · 84 citations

Life Sciences, Immunology, Pathology +17

Mycophenolate Mofetil Is Ineffective in the Treatment of Mucocutaneous Adamantiades-Behçet’s Disease

Y.D. Adler, Ulrich Mansmann, Ch.C. Zouboulis · Dermatology · 2001 · 66 citations

Medicine, Pharmacology, Pharmacotherapy +15

Multiple familial cutaneous glomangioma: A pedigree of 4 generations and critical analysis of histologic and genetic differences of glomus tumors

Ulrike Blume‐Peytavi, Y.D. Adler, Christoph C. Geilen et al. · Journal of the American Academy of Dermatology · 2000 · 54 citations

Medicine, Dermatology, Genetics +10

Comparative analysis of the association of HLA‐B*51 suballeles with Behçet’s disease in patients of German and Turkish origin

Ina Kötter, Nicole Stübiger, İzzet Fresko et al. · Tissue Antigens · 2001 · 47 citations

Life Sciences, Genetics, Immunology +17

Impact of atrial fibrillation on clinical status, atrial size and hemodynamics in patients after mitral valve replacement.

Mordehay Vaturi, Alik Sagie, Yaron Shapira et al. · PubMed · 2001 · 35 citations

Medicine, Cardiology, Surgery +17